# Ovidrel

NDC: 44087-1150
Generic name: choriogonadotropin alfa
Labeler / Manufacturer: EMD Serono, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20031006

FDA application: BLA021149

## Active ingredients

- CHORIOGONADOTROPIN ALFA: 250 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44087-1150"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44087-1150
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a683e58a-63ea-44b8-a326-1a99a537bcf2